The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy
The hormone, relaxin (RLX), exerts various organ-protective effects independently of etiology. However, its complex two-chain and three disulphide bonded structure is a limitation to its preparation and affordability. Hence, a single chain-derivative of RLX, B7–33, was developed and shown to retain...
Main Authors: | Fariha Alam, Tracey A. Gaspari, Barbara K. Kemp-Harper, Edward Low, Aaron Aw, Dorota Ferens, Iresha Spizzo, Ann-Maree Jefferis, Praveen Praveen, Robert E. Widdop, Ross A.D. Bathgate, Mohammed Akhter Hossain, Chrishan S. Samuel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223001580 |
Similar Items
-
Relaxin and related peptides : fifth international conference /
by: International Conference on Relaxin & Related Peptides (5th : 2008 : Maui, Hawaii), et al.
Published: (2009) -
Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design
by: Annunziata D'Ercole, et al.
Published: (2022-08-01) -
Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1
by: Anita A. Pinar, et al.
Published: (2020-08-01) -
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases
by: Alana Aragón-Herrera, et al.
Published: (2022-06-01) -
A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity
by: Praveen Praveen, et al.
Published: (2023-04-01)